TRANSCATHETER ELECTROSURGERY ADVANCED TECHNIQUES

Monday, March 10, 2025

2:52 PM – 3:48 PM ET

Moderator(s)

Amar Krishnaswamy, MD

Section Head, Interventional Cardiology
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Vasilis Babaliaros, MD

Emory University Hospital
Atlanta, GA, United States

Disclosure(s): Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Chris G. Bruce, MBChB

Interventional cardiologist
National Heart, Lung and Blood Institute
Bethesda, Maryland, United States

Disclosure(s): Transmural Sesame LLC: Consulting Fees (e.g., advisory boards) (Terminated, July 1, 2024)
Isida Byku, MD

Associate Professor, Structural/Interventional Cardiology
Emory University Hospital

Disclosure(s): Edwards Lifesciences: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Terminated)
Rim Halaby, MD

Interventional Cardiologist/Staff Clinician
National Institutes of Health/National Heart, Lung, and Blood Institute

Disclosure(s): No financial relationships to disclose
Jaffar M. Khan, MD, PhD

Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States

Disclosure(s): Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Jeremy D. Rier, DO

Interventional Cardiologist
WellSpan Health

Disclosure(s): Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Amar Krishnaswamy, MD: No financial relationships to disclose

Vasilis Babaliaros, MD: Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Chris G. Bruce, MBChB: Transmural Sesame LLC: Consulting Fees (e.g., advisory boards) (Terminated, July 1, 2024)

Isida Byku, MD: Edwards Lifesciences: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Terminated)

Rim Halaby, MD: No financial relationships to disclose

Jaffar M. Khan, MD, PhD: Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Jeremy D. Rier, DO: Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)